Clinical Trial Update: TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer [NA]

View source ↗

Summary

The TRTRM (ACTTOP) trial investigates a guided dosing strategy for older cancer patients. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: The University of Hong Kong | Conditions: Cancer (Solid Tumors), Geriatric Oncology | NA | Status: NOT_YET_RECRUITING